Moderna's AI-designed mRNA cancer vaccine succeeds in Phase 3 trial
Scobleizer · x · 2026-08-20
Moderna announced that an mRNA cancer vaccine designed using AI has succeeded in a Phase 3 clinical trial. This is considered a major breakthrough for AI in healthcare, signaling the technology's potential to accelerate cures for diseases, despite not yet being approved and serving currently as a treatment. The post also counters criticisms regarding AI's water usage and job displacement.
More from Apps
- Robinhood's new Platinum card includes $250 annual Waymo ride credit — reed · 2026-10-16
- ChatGPT's missing UTM tags confirmed as a bug, traffic attribution fully restored — lilyraynyc · 2026-10-16
- Tolan hailed as the AI product Steve Jobs would have built, per viral essay — ajaymehta · 2026-10-16
- Design Studio Runs Agentic Workflows on FLORA Canvas, From Prototype to Shipped Site — round · 2026-10-16
- AI agents have a 'normal-people problem': most users won't hand over their lives — examachine · 2026-10-16
- She planned a Napa trip with an AI planner, changed everything last minute — 'at least the car drove itself' — katieruthmishra · 2026-10-16